Mondo Visione Worldwide Financial Markets Intelligence

FTSE Mondo Visione Exchanges Index:

News Centre

  • HKEX Monthly Market Highlights

    Date 06/08/2024

    Highlights

    - Securities Market

    • Market capitalisation was $31.1 trillion at the end of July 2024.
    • The average daily turnover in July 2024 was $98.6 billion, while the average daily turnover for the first seven months of 2024 was $108.6 billion.
    • The average daily turnover of L&I Products for the first seven months of 2024 was $2.3 billion, an increase of 5 per cent when compared with $2.2 billion for the same period last year.
    • The average daily turnover of Debt Securities for the first seven months of 2024 was $560 million, an increase of 14 per cent when compared with $490 million for the same period last year.
    • There were 40 newly listed companies for the first seven months of 2024, an increase of 3 per cent when compared with 39* for the same period last year.

  • Non-Jordanian Ownership In Companies Listed On The Amman Stock Exchange Reached 47.2%, Of Which 33.0% For Institutional Investors

    Date 06/08/2024

    Amman Stock Exchange (ASE) revealed that the value of shares bought by non-Jordanian investors at the ASE in July 2024 was JD9.1 million, representing 9.4% of the overall trading value, while the value of shares sold by them amounted to JD12.0 million.

  • ISI Markets Announces Appointment Of Wes Schmidt As Chief Revenue Officer, Data & Analytics, Following Acquisition Of EPFR

    Date 06/08/2024

    ISI Markets is pleased to announce the appointment of Wes Schmidt as Chief Revenue Officer for its Data & Analytics offerings (EPFR & CEIC) on a global basis. This announcement follows the successful acquisition of EPFR, a strategic move that further expands ISI Markets’ global intelligence platform and rebrands the company as ISI Markets.

  • Rathbones Live With Iress’ Xplan

    Date 06/08/2024

    Iress today announces that Rathbones Group PLC (Rathbones) is now live on its Xplan advice software to support Rathbones' current financial planning business. Xplan will also be the financial planning platform of choice for Rathbones' upcoming integration with Investec Wealth & Investment, further enhancing the firm’s digital capabilities and enabling improved operational efficiency and client service.

  • Biotech IPO Raising Soars Sixfold QoQ in Q1 2024 Amid Renewed Investor Optimism, Reveals GlobalData

    Date 06/08/2024

    Biotech initial public offerings (IPOs) surged in the first quarter (Q1) of 2024, with eight completed IPOs raising $3.72 billion—six times the amount raised in Q4 2023 and marking the highest quarterly biotech IPO value in over a year on a quarter-on-quarter (QoQ) comparison. This increase followed a two-year decline, indicating pent-up demand. Going forward, robust clinical data may encourage more biotech companies to go public later in the year, according to GlobalData, a leading data and analytics company.